Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2005
12/22/2005US20050279927 Use of ultraphobic surfaces having a multitude of hydrophilic areas for analyzing samples
12/22/2005US20050278945 Small volume in vitro analyte sensor
12/22/2005DE10209245B4 Vorrichtung und Verfahren zur Detektion von Mikroorganismen Device and method for the detection of microorganisms
12/22/2005DE102004045186A1 Hydratisierte lamellare Phasen oder Liposomen, enthaltend ein Fettmonoamin oder ein kationisches Polymer, das die intrazelluläre Penetration begünstigt, und kosmetische oder pharmazeutische Zusammensetzungen, diese enthaltend, sowie Screeningverfahren nach einer solchen Substanz Hydrated lamellar phases or liposomes, containing a fatty mono-amine or a cationic polymer that promotes intracellular penetration, and cosmetic or pharmaceutical compositions comprising them, as well as screening methods for such substance
12/22/2005DE102004026494A1 Detecting specific nucleic acid comprises hybridizing peptide nucleic acid oligomer and DNA oligo where both sequences are complementary to the target and measuring fluorescent change upon mixing with target sequence which displaces oligo
12/22/2005DE102004026120A1 Adressierbare Molekülsondenanordnung Addressable molecular probe assembly
12/22/2005DE102004025780A1 Verfahren zur Anti-Limulus-Faktoren-unabhängigen Bestimmung der Lipopolysaccharid- und/oder Lipid-A- und/oder Glukan-Reaktivität, dafür geeignetes Testsystem sowie dessen Verwendung A method for anti-Limulus factors-independent determination of lipopolysaccharide and / or lipid-A and / or glucan-reactivity, but suitable test system and its use
12/22/2005DE102004025710A1 Verfahren zur taxonspezifischen Zellidentifizierung und Zellsortierung auf grampositive Bakterien und Vorrichtungen hierfür Process for the taxon cell identification and cell sorting on gram-positive bacteria and apparatus therefor
12/22/2005DE102004025580A1 Sensor-Anordnung, Sensor-Array und Verfahren zum Herstellen einer Sensor-Anordnung Sensor arrangement, the sensor array and method of manufacturing a sensor arrangement
12/22/2005DE102004025362A1 Use of TAK1 protein, or nucleic acid encoding it, for identifying compounds useful in treatment or prevention of bone atrophy, particularly osteoporosis
12/22/2005DE102004025360A1 Using transforming growth factor-beta-activated kinase-1, or its nucleic acid, for identifying agents useful in treatment or prevention of joint disease, especially arthritis
12/22/2005DE10160563B4 Verfahren zur Untersuchung der erblichen Infertilität des Mannes Method for investigating the man's hereditary infertility
12/22/2005DE10148750B4 Vorrichtung und Verfahren zur Detektion von Schimmelpilzbefall auf einer Oberfläche Device and method for the detection of mold growth on a surface
12/22/2005DE10120797B4 Verfahren zur Analyse von Nukleinsäureketten A process for the analysis of nucleic acid chains
12/22/2005CA2609260A1 Rna-containing microvesicles and methods therefor
12/22/2005CA2573551A1 Method for detecting a change in the conformational or energetic state of a molecular species
12/22/2005CA2572884A1 Identifying chromosomal abnormalities in cells obtained from follicular fluid
12/22/2005CA2570195A1 Polynucleotides and polypeptides involved in plant fiber development and methods of using same
12/22/2005CA2569959A1 Diagnosis and prognosis of wound infection by measurement of a phospholipase a2 in wound fluid
12/22/2005CA2569747A1 Real-time pcr point mutation assays for detecting hiv-1 resistance to antiviral drugs
12/22/2005CA2569667A1 Residual enzyme assay
12/22/2005CA2569597A1 Detection of dna mismatches and oxidative lesions
12/22/2005CA2569419A1 Double strand compositions comprising differentially modified strands for use in gene modulation
12/22/2005CA2569036A1 Chimeric gapped oligomeric compositions
12/22/2005CA2568735A1 Double strand compositions comprising differentially modified strands for use in gene modulation
12/22/2005CA2567899A1 Analyte sensors and methods for making and using them
12/22/2005CA2567793A1 Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1
12/22/2005CA2566501A1 Durable hydrophilic mouldable polymer composition, aqueous fluid channels based on said composition, microfluidic system incorporating said channels and method for the production thereof
12/22/2005CA2565678A1 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof
12/22/2005CA2564784A1 Episomal fusion gene
12/21/2005EP1607898A2 A bioinformatics system for functional proteomics modelling
12/21/2005EP1607748A1 Microchip, nucleic acid extracting kit, and nucleic acid extracting method
12/21/2005EP1607744A2 Treatment of diseases involving cyst formation with combinations comprising a PTBR agonist
12/21/2005EP1607743A1 Silane molecules with pre-activated and protein-resistant functionalities and silane films comprising such molecules
12/21/2005EP1607737A1 Device and method for detection and measurement of nucleic acid strands in solution
12/21/2005EP1607486A1 Method of stress evaluation
12/21/2005EP1607485A1 Method for quantifying VEGF121 isoform in a biological sample
12/21/2005EP1607481A1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
12/21/2005EP1607480A2 Method for synthesizing DNA
12/21/2005EP1607475A1 Oxygen indicator and packaged material
12/21/2005EP1607402A1 Method for the diagnosis of tumour
12/21/2005EP1606759A2 Methods to identify biologically active agents and synergistic combinations
12/21/2005EP1606633A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d3 (drd3)
12/21/2005EP1606627A2 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1b (pde1b)
12/21/2005EP1606626A2 Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c)
12/21/2005EP1606624A1 Method for the detection of a pathogenic form of a prion protein
12/21/2005EP1606622A2 Test methods for determining the intracellular concentration of cyclic nucleotides
12/21/2005EP1606621A2 Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar)
12/21/2005EP1606618A2 Test system for the discovery of substances for the promotion of neuraxonal growth
12/21/2005EP1606420A1 Method and kit for a specific detection of m.tuberculosis
12/21/2005EP1606419A1 Systems and methods for improving protein and milk production of dairy herds
12/21/2005EP1606418A1 Methods for the diagnosis and treatment of epilepsy
12/21/2005EP1606417A2 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna
12/21/2005EP1606416A2 Dna analyzing apparatus, dna sensor, and analyzing method
12/21/2005EP1606415A1 Lab-on-chip system for analyzing nucleic acid
12/21/2005EP1606408A2 Human p53 splice variant displaying differential transcriptional activity
12/21/2005EP1606404A2 Phosphokinase assay
12/21/2005EP1606402A1 Immunoadsorption of anti-von willebrand factor cleaving protease antibodies
12/21/2005EP1606399A2 Method of screening for target ligands
12/21/2005EP1606391A2 Virulent systemic feline calicivirus
12/21/2005EP1606389A2 Compositions and methods for polynucleotide sequence detection
12/21/2005EP1606305A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1606303A2 Detection and monitoring of lung cancer
12/21/2005EP1606048A2 Universal readout for target identification using biological microarrays
12/21/2005EP1605978A2 Therapeutic compositions
12/21/2005EP1605961A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1605953A2 Heterobifunctional polymeric bioconjugates
12/21/2005EP1605811A2 Expression profiles for breast cancer and methods of use
12/21/2005EP1603451A3 Amyloid plaque as a target for therapeutics that function by blocking or disrupting chitin synthesis or activity
12/21/2005EP1597559A3 Method and apparatus for detecting an analyte
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1543156A4 Detection of chemical ligation using fluorescence quenching leaving groups
12/21/2005EP1534865A4 Methods and compositions for determining methylation profiles
12/21/2005EP1511860A4 Improvements in and relating to a method of dna testing for------mycobacterium paratuberculosis strains
12/21/2005EP1509087A4 Treatment for diabetes
12/21/2005EP1499738A4 Recombinase polymerase amplification
12/21/2005EP1490383A4 Methods and compositions for identifying and characterizing hepatitis c
12/21/2005EP1438433A4 Detection of dna hybridization on surfaces
12/21/2005EP1402267B1 Chp for use as marker for sepsis
12/21/2005EP1381693A4 Apparatus and method for sequencing a nucleic acid
12/21/2005EP1337650A4 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation
12/21/2005EP1322670B1 Electrochemiluminescence from acridan compounds
12/21/2005EP1238067B1 Functional genomics using zinc finger proteins
12/21/2005EP1218518B1 Dna polymerase lambda and uses thereof
12/21/2005EP1165815B1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus
12/21/2005EP1146332B1 Glucose sensor
12/21/2005EP1112375B1 Biosensor
12/21/2005EP1098193B1 Method for assaying l-phenylalanine and l-phenylalanine sensor
12/21/2005EP1070139B1 Assay for asymmetrical dimethyl-l-arginine (adma)
12/21/2005EP1025259B1 Method for adjusting and disinfecting liquids
12/21/2005EP1007733B1 Universal solid-phase hybridization apparatus
12/21/2005EP0979235B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof
12/21/2005EP0828856B1 Nucleic acid detection and amplification by chemical linkage of oligonucleotides
12/21/2005EP0702692B1 Regulation of antigen presentation
12/21/2005CN1711472A Measuring instrument provided with sold component concentrating means
12/21/2005CN1711361A Methods to predict edema as a side effect of drug treatment
12/21/2005CN1711360A Marker gene
12/21/2005CN1711359A Method of identifying and assessing DNA euchromatin for detecting disease
12/21/2005CN1711358A Methods, compositions and computer software products for interrogating sequence variations in functional genomic regions
12/21/2005CN1711357A One step real-time RT PCR kits for the universal detection of organisms in industrial products
1 ... 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 ... 3003